Anebulo Pharmaceuticals
ANEB
ANEB
12 hedge funds and large institutions have $21.6M invested in Anebulo Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
5
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$45.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.3K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.29K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$5.07K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 |
BlackRock
New York
|
-$9.35K |
| 2 |
PP
Praetorian PR
Rincon,
Puerto Rico
|
-$8.29K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $15.5M | – | – | – |
|
|
LA
2
LVW Advisors
Pittsford,
New York
| $2.05M | – | – | – |
|
|
NCM
3
Nantahala Capital Management
New Canaan,
Connecticut
| $1.56M | – | – | – |
|
|
MP
4
Mangrove Partners
Greenwich,
Connecticut
| $1.22M | – | – | – |
|
|
PP
5
Praetorian PR
Rincon,
Puerto Rico
| $542K | -$8.29K | -2,713 | -2% |
|
|
IC
6
Ikarian Capital
Dallas,
Texas
| $504K | +$5.29K | +1,659 | +1% |
|
|
7
Vanguard Group
Malvern,
Pennsylvania
| $68.3K | +$19.3K | +6,312 | +39% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $63.7K | +$45.1K | +14,750 | +242% |
|
|
BFM
9
Boothbay Fund Management
New York
| $58K | +$5.07K | +1,659 | +10% |
|
|
10
BlackRock
New York
| $12.8K | -$9.35K | -3,060 | -42% |
|
|
11
Wells Fargo
San Francisco,
California
| $177 | +$3 | +1 | +2% |
|